EDQM submissions, including Certificate of Suitability (CEP) and Certificate of Suitability for excipients (COS), are critical regulatory approvals for pharmaceutical substances intended for use in the European market. Our EDQM Submissions (CEP/COS) services support API and excipient manufacturers in preparing, submitting, and maintaining high-quality dossiers that comply with European Pharmacopoeia (Ph. Eur.) standards and EDQM requirements.
We provide end-to-end regulatory support to help you achieve successful CEP/COS approvals and maintain ongoing compliance.
End-to-End EDQM (CEP / COS) Submission Support
Our services cover the complete lifecycle of EDQM submissions—from initial gap assessment to approval and post-approval maintenance.
Scope of EDQM Submission Services
- CEP / COS Strategy & Feasibility Assessment
- Assessment of Ph. Eur. monograph applicability
- Regulatory pathway and submission strategy
- Gap analysis against EDQM and Ph. Eur. requirements
- Readiness assessment of manufacturing sites and processes
- Dossier Preparation & Compilation
- Preparation of CEP dossiers as per EDQM format
- Manufacturing process description and controls
- Control of materials, impurities, and elemental impurities
- Analytical methods and validation data
- Quality & GMP Compliance Support
- Alignment with EU GMP and ICH Q7 requirements
- Site Master File (SMF) preparation and review
- GMP inspection readiness for EDQM audits
- Change control and regulatory commitment documentation
- Submission, Review & Deficiency Management
- CEP/COS submission to EDQM
- Response to EDQM deficiency letters
- Clarifications, data justifications, and dossier updates
- Regulatory communication support
- Lifecycle Management & Maintenance
- CEP/COS renewals and variations
- Annual updates and change management
- Support during EDQM inspections and re-evaluations
Regulatory Standards & Guidelines Covered
Our EDQM services are aligned with:
- European Pharmacopoeia (Ph. Eur.)
- EDQM CEP & COS Guidelines
- EU GMP Requirements
- ICH Q7, Q9, Q10
- ICH Q3 (Impurities & Elemental Impurities)
- EMA & European regulatory expectations
This ensures acceptance across European Union member states.
Risk-Based & Regulator-Focused Approach
We follow a science-driven and risk-based approach focused on impurity control, process consistency, and pharmacopoeial compliance—key focus areas for EDQM reviewers.
Key Deliverables
- Complete CEP/COS submission dossier
- Gap assessment and remediation report
- Regulatory-compliant technical documentation
- EDQM deficiency responses and follow-up support
- Inspection-ready compliance packages
Why Choose Our EDQM (CEP / COS) Services?
- Specialized European Regulatory Expertise
Strong understanding of EDQM and Ph. Eur. expectations. - High-Quality Dossier Writing
Clear, consistent, and reviewer-friendly submissions. - Inspection & Deficiency Focused
Prepared to withstand EDQM reviews and inspections. - End-to-End Lifecycle Support
From feasibility to approval and maintenance. - Confidential & Secure Handling
Strict control of sensitive technical data.
Industries We Support
- API Manufacturers
- Excipient Manufacturers
- Pharmaceutical Intermediates Manufacturers
- Export-Oriented Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
Achieve European Market Access with Confidence
With increasing scrutiny on Ph. Eur. compliance, impurity profiles, and GMP systems, successful EDQM (CEP/COS) submissions require precision, expertise, and regulatory insight. Our structured approach helps you achieve approvals efficiently and maintain long-term compliance.
